Dombrowski sees no clear cut answer to Chris Froome's salbutamol case

EF-Education First-Drapac rider Joe Dombrowksi feels there is no clear cut answer to the rights and wrongs of Chris Froome's decision to continue with a normal race program despite the Briton's Adverse Analytical Finding for salbutamol during the 2017 Vuelta a Espana.

Alasdair Fotheringham

Alasdair Fotheringham has been reporting on cycling since 1991. He has covered every Tour de France since 1992 bar one, as well as numerous other bike races of all shapes and sizes, ranging from the Olympic Games in 2008 to the now sadly defunct Subida a Urkiola hill climb in Spain. As well as working for Cyclingnews, he has also written for The IndependentThe GuardianProCycling, The Express and Reuters.